App-Quantinova.ai

Innate immune populations contribute to effective immune responses against B lymphoblastic leukemia cells (P1118)

Rae Hunter - American Association of Immunologists (AAI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

IL-12

B cell transcription factors define a novel tumor suppressor gene network In ALL (P1119)

Lynn M Heltemes Harris - American Association of Immunologists (AAI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

Overexpression of LLT1 (CLEC2D) in childhood Acute Lymphoblastic Leukemia (ALL) (P1120)

Stephen O Mathew - American Association of Immunologists (AAI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

Tumor-associated myeloid cells provide critical support for T-ALL in vivo (P1105)

Aram Lyu - American Association of Immunologists (AAI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

Promoting anti-tumor immunity via bispecific T cell engaging cytokine (biteokine) therapy (P1312)

Priscilla Do - American Association of Immunologists (AAI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Blinatumomab

An engineered IL-2 partial agonist promotes CD8+ T cell stemness and anti-tumor efficacy (P216)

Fei Mo - American Association of Immunologists (AAI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

Immunotherapy for solid tumors: Chimeric antigen receptor (CAR) T-cells and the tumor microenvironment (P1071)

Chiadika Nwanze - American Association of Immunologists (AAI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Acute lymphoblastic leukemia

N/A

Targeting REGNASE-1 improves efficacy of chimeric antigen receptor T cell therapy for leukemia (P1073)

Wenting Zheng - American Association of Immunologists (AAI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

Fasting Mimicking Diet promotes immunotherapy-associated changes and inhibits autophagy to promote cancer free survival in Acute Lymphoblastic Leukemia models. (P1085)

Roberta Buono - American Association of Immunologists (AAI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Vincristine

A new Natural Killer cell therapy to target relapse Acute Lymphoblastic Leukemia (P1135)

Yorleny M Vicioso - American Association of Immunologists (AAI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acute lymphoblastic leukemia

Vactosertib

Impact of Vertebral Fracture on Auxological Profile and Insulin-Like Growth Factors of Children After Acute Lymphoblastic Leukemia Treatment

Moon Bae Ahn - Endocrine Society (ENDO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Mecasermin

Hemorrhagic manifestations in pediatric acute lymphoblastic leukemia: Beyond thrombocytopenia

M. Elshinawy - European Association for Haemophilia and Allied Disorders (EAHAD) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

SAFE TARGETING OF T‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA BY SUBUNIT SELECTIVE GAMMA‐SECRETASE INHIBITION

Charles de Bock - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

MRK560

BENEFITS OF RNA SEQUENCING IN DETECTING RECURRENT AND NOVEL FUSION TRANSCRIPTS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Rabia Shahswar - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

IN VITRO AND IN VIVO STUDIES OF NOVEL ASPARAGINASE MUTANTS FOR THE TREATMENT OF ACUTE LYMPHATIC LEUKEMIA

Soumika Sengupta - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Asparaginase

“3C-UP” A NEW ADULT PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA SUBGROUP: NOVEL MOLECULAR MARKERS

Anna Ferrari - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acute lymphoblastic leukemia

N/A

ADULT TRIPLE NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA FUSION DETECTION: CHALLENGING AIM FOR PH- ALTERNATIVE THERAPIES

Anna Ferrari - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acute lymphoblastic leukemia

N/A

NOVEL PHARMACOGENOMIC AND PHARMACOTRANSCRIPTOMIC MARKERS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

Vladimir Gaic - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

APPLICABILITY OF DROPLET DIGITAL PCR (DDPCR) FOR MINIMAL RESIDUAL DISEASE MONITORING (MRD) IN PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

Sabina Chiaretti - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

ADAM28 OVEREXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA PROMOTE ITS INVASION IN CENTRAL NEURAL SYSTEM VIA CROSS TALKING WITH CXCR4 PATHWAY

Chencong Wang - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

Filters

2187 Abstracts